{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:04:36Z","timestamp":1785549876308,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T00:00:00Z","timestamp":1254787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1038\/sj.bjc.6605347","type":"journal-article","created":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T16:00:55Z","timestamp":1254844855000},"page":"1549-1554","source":"Crossref","is-referenced-by-count":34,"title":["A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605)"],"prefix":"10.1038","volume":"101","author":[{"name":"JCOG Lung Cancer Study Group, Tokyo, Japan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kunitoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Nishiwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,6]]},"reference":[{"key":"BF6605347_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/sj.bjc.6690773","volume":"81","author":"A Berruti","year":"1999","unstructured":"Berruti A, Borasio P, Gerbino A, Gorzegno G, Moschini T, Tampellini M, Ardissone F, Brizzi MP, Dolcetti A, Dogliotti L (1999) Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience. Br J Cancer 81: 841\u2013845","journal-title":"Br J Cancer"},{"key":"BF6605347_CR2","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1200\/JCO.1988.6.11.1722","volume":"6","author":"WJ Curran Jr","year":"1988","unstructured":"Curran Jr WJ, Kornstein MJ, Brooks JJ, Turrisi 3rd AT (1988) Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 6: 1722\u20131727","journal-title":"J Clin Oncol"},{"key":"BF6605347_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ijrobp.2003.11.021","volume":"59","author":"TY Eng","year":"2004","unstructured":"Eng TY, Fuller CD, Jagirdar J, Bains Y, Thomas Jr CR (2004) Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys 59: 654\u2013664","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6605347_CR4","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/JCO.1990.8.8.1419","volume":"8","author":"A Fornasiero","year":"1990","unstructured":"Fornasiero A, Daniele O, Ghiotto C, Sartori F, Rea F, Piazza M, Fiore-Donati L, Morandi P, Aversa SM, Paccagnella A, Pappagallo GL, Fiorentino MV (1990) Chemotherapy of invasive thymoma. J Clin Oncol 8: 1419\u20131423","journal-title":"J Clin Oncol"},{"key":"BF6605347_CR5","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1200\/JCO.2006.09.6198","volume":"25","author":"B Freidlin","year":"2007","unstructured":"Freidlin B, Korn EL, Hunsberger S, Gray R, Saxman S, Zujewski JA (2007) Proposal for the use of progression-free survival in unblinded randomized trials. J Clin Oncol 25: 2122\u20132126","journal-title":"J Clin Oncol"},{"key":"BF6605347_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/bjc.1997.50","volume":"75","author":"M Fukuoka","year":"1997","unstructured":"Fukuoka M, Masuda N, Negoro S, Matsui K, Yana T, Kudoh S, Kusunoki Y, Takada M, Kawahara M, Ogawara M, Kodama N, Kubota K, Furuse K (1997) CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer. Br J Cancer 75: 306\u2013309","journal-title":"Br J Cancer"},{"key":"BF6605347_CR7","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1200\/JCO.1998.16.6.2126","volume":"16","author":"K Furuse","year":"1998","unstructured":"Furuse K, Fukuoka M, Nishiwaki Y, Kurita Y, Watanabe K, Noda K, Ariyoshi Y, Tamura T, Saijo N (1998) Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. J Clin Oncol 16: 2126\u20132132","journal-title":"J Clin Oncol"},{"key":"BF6605347_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/01.cco.0000152628.43867.8e","volume":"17","author":"G Giaccone","year":"2005","unstructured":"Giaccone G (2005) Treatment of malignant thymoma. Curr Opin Oncol 17: 140\u2013146","journal-title":"Curr Opin Oncol"},{"key":"BF6605347_CR9","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","volume":"14","author":"G Giaccone","year":"1996","unstructured":"Giaccone G, Ardizzoni A, Kirkpatrick A, Clerico M, Sahmoud T, van Zandwijk N (1996) Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 14: 814\u2013820","journal-title":"J Clin Oncol"},{"key":"BF6605347_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/JTO.0b013e31818e105c","volume":"4","author":"N Girard","year":"2009","unstructured":"Girard N, Mornex F, Van Houtte P, Cordier JF, van Schil P (2009) Thymoma: a focus on current therapeutic management. J Thorac Oncol 4: 119\u2013126","journal-title":"J Thorac Oncol"},{"key":"BF6605347_CR11","first-page":"923","volume":"67","author":"JH Goldie","year":"1983","unstructured":"Goldie JH, Coldman AJ (1983) Quantitative model for multiple levels of drug resistance in clinical tumors. Cancer Treat Rep 67: 923\u2013931","journal-title":"Cancer Treat Rep"},{"key":"BF6605347_CR12","first-page":"3643","volume":"44","author":"JH Goldie","year":"1984","unstructured":"Goldie JH, Coldman AJ (1984) The genetic origin of drug resistance in neoplasms: implications for systemic therapy. Cancer Res 44: 3643\u20133653","journal-title":"Cancer Res"},{"key":"BF6605347_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/sj.bmt.1703181","volume":"28","author":"N Hanna","year":"2001","unstructured":"Hanna N, Gharpure VS, Abonour R, Cornetta K, Loehrer Sr PJ (2001) High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience. Bone Marrow Transplant 28: 435\u2013438","journal-title":"Bone Marrow Transplant"},{"key":"BF6605347_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","volume":"44","author":"ES Kim","year":"2004","unstructured":"Kim ES, Putnam JB, Komaki R, Walsh GL, Ro JY, Shin HJ, Truong M, Moon H, Swisher SG, Fossella FV, Khuri FR, Hong WK, Shin DM (2004) Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44: 369\u2013379","journal-title":"Lung Cancer"},{"issue":"15S","key":"BF6605347_CR15","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.1200\/jco.2008.26.15_suppl.8018","volume":"26","author":"GL Lemma","year":"2008","unstructured":"Lemma GL, Loehrer Sr PJ, Lee JW, Langer CJ, Tester WJ, Johnson DH (2008) A phase II study of carboplatin plus paclitaxel in advanced thymoma or thymic carcinoma: E1C99. J Clin Oncol 26 (15S): abstract 8018","journal-title":"J Clin Oncol"},{"key":"BF6605347_CR16","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1200\/JCO.1987.5.5.756","volume":"5","author":"L Levin","year":"1987","unstructured":"Levin L, Hryniuk WM (1987) Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. J Clin Oncol 5: 756\u2013767","journal-title":"J Clin Oncol"},{"key":"BF6605347_CR17","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","volume":"15","author":"PJ Loehrer Sr","year":"1997","unstructured":"Loehrer Sr PJ, Chen M, Kim K, Aisner SC, Einhorn LH, Livingston R, Johnson D (1997) Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 15: 3093\u20133099","journal-title":"J Clin Oncol"},{"key":"BF6605347_CR18","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","volume":"91","author":"PJ Loehrer Sr","year":"2001","unstructured":"Loehrer Sr PJ, Jiroutek M, Aisner S, Aisner J, Green M, Thomas Jr CR, Livingston R, Johnson DH (2001) Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 91: 2010\u20132015","journal-title":"Cancer"},{"key":"BF6605347_CR19","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","volume":"12","author":"PJ Loehrer Sr","year":"1994","unstructured":"Loehrer Sr PJ, Kim K, Aisner SC, Livingston R, Einhorn LH, Johnson D, Blum R (1994) Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 12: 1164\u20131168","journal-title":"J Clin Oncol"},{"issue":"18S","key":"BF6605347_CR20","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1200\/jco.2006.24.18_suppl.7079","volume":"24","author":"PJ Loehrer Sr","year":"2006","unstructured":"Loehrer Sr PJ, Yiannoutsos CT, Dropcho S, Burns M, Helft P, Chiorean EG, Nelson RP (2006) A phase II trial of pemetrexed in patients with recurrent thymoma or thymic carcinoma. J Clin Oncol 24 (18S): abstract 7079","journal-title":"J Clin Oncol"},{"key":"BF6605347_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/01243894-200605000-00007","volume":"1","author":"M Lucchi","year":"2006","unstructured":"Lucchi M, Melfi F, Dini P, Basolo F, Viti A, Givigliano F, Angeletti CA, Mussi A (2006) Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up. J Thorac Oncol 1: 308\u2013313","journal-title":"J Thorac Oncol"},{"key":"BF6605347_CR22","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"A Masaoka","year":"1981","unstructured":"Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48: 2485\u20132492","journal-title":"Cancer"},{"key":"BF6605347_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207\u2013214","journal-title":"Cancer"},{"key":"BF6605347_CR24","first-page":"20","volume":"14","author":"N Murray","year":"1987","unstructured":"Murray N (1987) The importance of dose and dose intensity in lung cancer chemotherapy. Semin Oncol 14: 20\u201328","journal-title":"Semin Oncol"},{"key":"BF6605347_CR25","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1200\/JCO.1991.9.9.1632","volume":"9","author":"N Murray","year":"1991","unstructured":"Murray N, Shah A, Osoba D, Page R, Karsai H, Grafton C, Goddard K, Fairey R, Voss N (1991) Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer. J Clin Oncol 9: 1632\u20131638","journal-title":"J Clin Oncol"},{"key":"BF6605347_CR26","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/cncr.10373","volume":"94","author":"K Ogawa","year":"2002","unstructured":"Ogawa K, Uno T, Toita T, Onishi H, Yoshida H, Kakinohana Y, Adachi G, Itami J, Ito H, Murayama S (2002) Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer 94: 1405\u20131413","journal-title":"Cancer"},{"key":"BF6605347_CR27","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/cncr.10226","volume":"94","author":"M Okumura","year":"2002","unstructured":"Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, Tada H, Eimoto T, Matsuda H, Masaoka A (2002) The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94: 624\u2013632","journal-title":"Cancer"},{"key":"BF6605347_CR28","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","volume":"22","author":"P Strobel","year":"2004","unstructured":"Strobel P, Bauer A, Puppe B, Kraushaar T, Krein A, Toyka K, Gold R, Semik M, Kiefer R, Nix W, Schalke B, Muller-Hermelink HK, Marx A (2004) Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 22: 1501\u20131509","journal-title":"J Clin Oncol"},{"key":"BF6605347_CR29","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1200\/JCO.1999.17.7.2280","volume":"17","author":"CR Thomas","year":"1999","unstructured":"Thomas CR, Wright CD, Loehrer PJ (1999) Thymoma: state of the art. J Clin Oncol 17: 2280\u20132289","journal-title":"J Clin Oncol"},{"key":"BF6605347_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/oxfordjournals.jjco.a039642","volume":"23","author":"K Tobinai","year":"1993","unstructured":"Tobinai K, Kohno A, Shimada Y, Watanabe T, Tamura T, Takeyama K, Narabayashi M, Fukutomi T, Kondo H, Shimoyama M, Suemasu K (1993) Toxicity grading criteria of the Japan Clinical Oncology Group. The Clinical Trial Review Committee of the Japan Clinical Oncology Group. Jpn J Clin Oncol 23: 250\u2013257","journal-title":"Jpn J Clin Oncol"},{"key":"BF6605347_CR31","volume-title":"Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart","author":"WB Travis","year":"2004","unstructured":"Travis WB, Brambilla E, Muller-Hermelinck HK, Harris CC (2004) Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press: Lyon"},{"key":"BF6605347_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0167-8140(90)90154-O","volume":"19","author":"A Urgesi","year":"1990","unstructured":"Urgesi A, Monetti U, Rossi G, Ricardi U, Casadio C (1990) Role of radiation therapy in locally advanced thymoma. Radiother Oncol 19: 273\u2013280","journal-title":"Radiother Oncol"},{"key":"BF6605347_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/JTO.0b013e31802bafc8","volume":"2","author":"K Yokoi","year":"2007","unstructured":"Yokoi K, Matsuguma H, Nakahara R, Kondo T, Kamiyama Y, Mori K, Miyazawa N (2007) Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. J Thorac Oncol 2: 73\u201378","journal-title":"J Thorac Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605347","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:42:13Z","timestamp":1684399333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,6]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["BF6605347"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605347","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,6]]}}}